PRALUENT

sanofi-aventis canada inc🇨🇦 Health Canada

Approval Id: 0f0ff0cffa1a41b1
Drug Approval Canada Name: PRALUENT
Product Name: PRALUENT
Status: Marketed
Status Date: 2016-05-18
Original Market Date: 2016-05-18
Din: 02453819
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Prescription , Schedule D
Ahfs: 24:06.24
Atc Original: C10AX14 ALIROCUMAB
Atc Name: c 10 ax 14
Aig Number: 0158030001
Company Name: sanofi-aventis canada inc
Company Address: 1755 Steeles Avenue West, Toronto, Ontario, Canada, M2R 3T4

ALIROCUMAB

75 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

0f0ff0cffa1a41b1

Type

Standard